Market Overview
Size, architecture, and verification shift
- Brevintel analysis values the spice adulteration testing market at USD 930 million in 2025 ($930M), with USD 995.1 million expected in 2026 and a path to USD 1.8 billion ($1.8B) by 2035 at a 7% CAGR over 2026-2035.
- The detailed forecast path runs from USD 930.0 million in 2025 to USD 1,829.5 million in 2035, matching the 1.8 billion headline while keeping both card values and the long-form 2035 total in view.
- Eurofins Scientific SE led with over 14% share in 2025, while Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bureau Veritas SA, and QIAGEN N.V. together held 47.7%.
- Demand is shifting from incident-led inspection to documented verification across procurement, processing, and import clearance, so an analytical record is becoming commercial evidence for market access.
- Brevintel analysis treats 7.0% growth as a two-tier architecture: rapid screening near intake and export preparation, with accredited laboratories reserved for quantified hazards and enforcement-grade certificates.
- India reported spice exports of USD 4.72 billion in FY2025, up 6% from FY2024, with chilli, cumin, turmeric, and spice oils and oleoresins among important export categories.
- India received 183 importing-country rejection or recall alerts across an estimated 31,813 spice consignments in FY2023 to 24, while Spices Board quality-evaluation laboratories analyzed 150,004 parameters in export samples.
- That combination makes pre-shipment evidence an operating requirement for exporters rather than a discretionary quality signal, and it keeps screening and reference methods interoperable through sampling protocols and escalation rules.
Incident evidence and enforcement context
- A European coordinated control plan covering 1,885 herb and spice samples found 17% suspicious for adulteration, with suspicion at 48% for oregano versus 17% for pepper, 14% for cumin, 11% for turmeric and saffron, and 6% for paprika/chilli.
- Those November 2021 findings show why botanical substitution, added dyes, metals, residues, and contaminants require different analytical responses rather than a single screen.
- A later Joint Research Centre review of 104 retail cinnamon samples found that more than 66% did not meet international quality standards; 9.6% exceeded the EU lead limit of 2 mg/kg and 31 samples contained coumarin concentrations potentially hazardous to children.
- The FDA identifies food fraud as a material global economic issue, and its 2024 cinnamon-applesauce response linked elevated lead and chromium to intentional lead chromate addition, prompting recalls and import-control activity.
- Import Alert 99-42 activity in 2024-2026, together with FSMA preventive-control and traceability expectations, raises the value of accredited methods, chain-of-custody records, and lot-linked certificates.
- A 25-laboratory validation of 13 qPCR methods across paprika/chilli, saffron, cumin, turmeric, oregano, and black pepper was designed to support standardization for official controls.
- FSSAI ran national surveillance covering 13 spice commodities between November 2024 and February 2025, followed by an October 2025 manufacturing enforcement drive across those categories.
- DNA barcoding work published in 2023 showed non-conformities that visual inspection cannot reliably catch in processed spice material, reinforcing species authentication alongside chemical panels.
Market Dynamics
Drivers
- Testing demand begins with failure modes visible to regulators: the EU oregano result was largely associated with olive-leaf substitution, while chemical-risk cases such as the FDA cinnamon response can become acute public-health events.
- A buyer sourcing turmeric, chilli, cumin, or cinnamon may need species authentication, synthetic-dye analysis, heavy-metal determination, residue screening, and microbiological controls on the same lot.
- The U.S. Food Safety Modernization Act framework requires preventive controls, and the Food Traceability Rule adds recordkeeping for designated foods, making accredited evidence more durable than incident-led spend.
- Europe is advancing official controls and method harmonization so a supplier-assurance result is less likely to be rejected or retested in a destination market.
- India’s direction of travel is toward testing at processing sites, creating demand for local sampling, accredited throughput, and portable triage rather than only border testing.
- Trade multiplies handoffs where provenance can be obscured; high-value commodities intensify substitution incentives, while blends hide the point at which a non-conforming ingredient entered the chain.
- The EU Deforestation Regulation introduced geolocation-related diligence for relevant supply chains, and U.S. traceability rules reinforce the need to associate records with custody events.
- Providers that integrate sampling, digital certificates, and retest triggers can compete on reduced release risk, not only on instrument sensitivity.
Restraints and tiered-testing response
- HPLC, GC-MS, ICP-MS, sequencing, and digital PCR require installation, calibration, consumables, validated methods, and trained analysts, so small processors often outsource and accept transport and queue delays.
- A rapid screen can identify lots that merit escalation, but regulatory or contractual decisions on low-level contaminants still require confirmatory laboratory work.
- Production countries do not have uniform access to accredited networks, cold-chain sample logistics, or specialist analysts, so testing may be deferred until an importer requires it.
- FSSAI requires enforcement samples to be examined through NABL-accredited laboratories, but origin-side systems still need throughput and geographic coverage to make routine screening practical.
- In a peer-reviewed coriander study, benchtop, portable Flame-NIR, and handheld SCiO instruments correctly classified all adulterated samples in the external validation set, while portable and handheld devices were weaker for low-level quantification.
- India has 305 Mobile Food Testing Laboratories across 35 States and Union Territories, alongside 259 NABL-accredited food-testing laboratories and 24 referral laboratories; those figures are cross-category, not spice-specific.
- Brevintel analysis assigns a -2.5% CAGR impact to advanced-testing cost; selective confirmation is the mechanism most likely to reduce that drag without treating a screening result as final proof.
- The constraint favors providers that combine standardized field collection with regional laboratory networks and transparent escalation criteria.
Segmentation Analysis
Testing technology
- Chromatography-based testing remained the largest technology segment at 32.5% of the market, or USD 302.3 million, in 2025 and is projected to reach USD 407.7 million by 2035 at a 2.8% CAGR.
- HPLC and GC-MS support dyes, residue, and organic-profile analysis, while ICP-MS is central to elemental determinations when a buyer needs a quantitatively defensible result.
- Spectroscopy-based testing accounted for 24.5% of 2025 revenue, or USD 227.9 million, and is expected to reach USD 501.2 million by 2035 at an 8.2% CAGR on speed and non-destructive triage.
- A multi-country handheld NIR study reported correct classification of adulteration samples on 33 of 34 devices, and handheld LIBS has shown rapid screening potential for illegal dyes in paprika powder.
- Molecular/DNA-based testing represented 10.0% of the market, or USD 93.0 million, in 2025 and is projected to reach USD 292.7 million by 2035 at an 11.9% CAGR on botanical-substitution specificity.
- The qPCR validation across six spice matrices demonstrated reproducible quantification at low adulterant concentrations, while next-generation sequencing and metabarcoding help when an unknown botanical component is present in blends.
- Sensor and AI-enabled testing was smaller at 5.5%, or USD 51.2 million, in 2025, but is projected to reach USD 284.2 million by 2035 at a 17.1% CAGR as risk assessment moves nearer to farms, docks, and borders.
- Immunoassay-based testing accounted for 10.5%, or USD 97.7 million, in 2025 and is expected to reach USD 164.4 million by 2035 at a 5.4% CAGR for allergens and mycotoxins.
- Physical and microscopy-based testing held 11.5%, or USD 107.0 million, and reaches USD 124.8 million by 2035 at a 2.0% CAGR, retaining a role in extraneous-matter and gross-adulteration checks.
Adulteration type
- Chemical adulterant detection was the largest application, with a 33.5% share, or USD 311.6 million, in 2025, rising to USD 557.0 million by 2035 at a 6.0% CAGR as synthetic colorants and heavy metals demand quantitative determination.
- FDA action on lead-containing cinnamon products shows the direct route from chemical fraud detection to recalls, supplier remediation, and import controls.
- Biological/botanical adulterant detection accounted for 27.5%, or USD 255.8 million, and is projected to reach USD 540.7 million by 2035 at a 7.8% CAGR, covering substitutions such as olive leaves in oregano, caraway in cumin, and non-saffron material in saffron.
- Contaminant detection represented 18.5%, or USD 172.1 million, and reaches USD 366.2 million by 2035 at a 7.9% CAGR, benefiting from shared laboratory infrastructure for residues, metals, and mycotoxins.
- Microbiological contamination testing is the fastest-growing adulteration-type segment at an 8.5% CAGR, increasing from USD 125.6 million in 2025 to USD 283.4 million by 2035.
- Food-safety controls for pathogens and counts expand the testing bundle even when the commercial concern began as authenticity, so cross-method laboratory capability becomes a retention factor.
Spice type
- Seed spices were the largest spice-type segment at 20.5%, or USD 190.7 million, in 2025, growing at a 5.1% CAGR as cumin, coriander, fennel, and fenugreek combine volume with botanical-substitution exposure.
- Root and rhizome spices accounted for 18.0%, or USD 167.4 million, and grow at 7.3% CAGR, supported by testing needs in turmeric and ginger.
- Fruit and berry spices held 15.0%, or USD 139.5 million, and are projected to reach USD 283.7 million by 2035 at a 7.4% CAGR.
- Flower and stigma spices represented 12.5%, or USD 116.3 million, in 2025 and reach USD 246.4 million by 2035 at a 7.8% CAGR, reflecting saffron’s high unit value and validated qPCR detection of defined botanical adulterants.
- Bark spices accounted for 10.0%, or USD 93.0 million, and grow at 7.0% CAGR, while herb-based spices and dried leaves represented 12.0%, or USD 111.6 million, and grow at 7.9% CAGR.
- Cinnamon and oregano findings show why bark and herb risk profiles demand more than ordinary visual quality checks.
- Spice blends and mixed seasonings formed 9.0% of 2025 revenue, or USD 83.7 million, but are the fastest-growing spice-type segment at 8.6% CAGR, reaching USD 192.1 million by 2035.
- Brevintel analysis notes that blend economics exceed the market rate because one submission often must resolve species identity, chemical risk, and microbiological acceptability together.
End user
- Food manufacturers and processors led with a 41.5% share, or USD 386 million, in 2025 and are projected to reach USD 797.5 million by 2035 at a 7.5% CAGR as they qualify suppliers and release raw materials without disrupting production.
- Third-party testing laboratories accounted for 28.0%, or USD 260.4 million, and are expected to reach USD 584.2 million by 2035 at an 8.4% CAGR, giving smaller manufacturers accredited panels and larger ones surge capacity.
- Government and regulatory bodies accounted for 15.5%, or USD 144.2 million, in 2025 and grow at 5.5% CAGR.
- Research and academic institutions represented 8.5%, or USD 79.1 million, growing at 4.9% CAGR.
- The remaining end-user category held 6.5%, or USD 60.5 million, and reaches USD 72.6 million by 2035 at a 2.0% CAGR.
- Procurement increasingly hinges on turnaround, accreditation scope, and the ability to translate a result into a release, hold, or corrective-action decision.
Regional Outlook
North America and Europe
- North America is the largest market, holding 33.0% of 2025 revenue, or USD 306.9 million, and is projected to reach USD 558.0 million by 2035 at a 6.1% CAGR.
- The U.S. contributes USD 267.3 million in 2025, with FDA import controls and the cinnamon-related recall response making heavy-metal and authenticity documentation commercially important for importers and food manufacturers.
- FSMA-related preventive-control and traceability expectations reinforce demand for records that connect an analytical result to the relevant lot and supplier.
- Europe accounts for 28.0%, or USD 260.4 million, in 2025 and reaches USD 475.7 million by 2035 at a 6.2% CAGR as coordinated surveillance creates repeatable demand for accredited laboratory services.
- The Joint Research Centre cinnamon investigation published on September 24, 2025, and the development of validated qPCR methods for official controls, point to a regional market where harmonized evidence is increasingly valuable.
- North America and Europe will continue to reward traceable, reference-grade outcomes rather than isolated incident testing.
Asia Pacific, Latin America, and Middle East & Africa
- Asia Pacific represents 25.0%, or USD 232.5 million, in 2025 and is the fastest-growing region at an 8.8% CAGR, reaching USD 539.7 million by 2035.
- China, India, Japan, Australia, South Korea, and the rest of Asia Pacific each contribute to a more distributed pattern of demand than an import-only model would suggest.
- The Spices Board’s FY2023 to 24 record of 183 alerts across 31,813 consignments, together with eight Board quality-evaluation laboratories and 19 empanelled NABL-accredited private laboratories, indicates an established export-testing base.
- India’s notified network of 259 NABL-accredited food-testing laboratories, 24 referral laboratories, and 305 mobile laboratories provides relevant cross-category infrastructure for origin-side screening and confirmation.
- The reported rise in food recalls from 754 in FY2024 to 25 to 1,147 in FY2025 to 26 is cross-category, not spice-specific, but signals more active food-safety enforcement.
- Latin America holds 8.0%, or USD 74.4 million, in 2025 and is projected to reach USD 164.7 million by 2035 at an 8.3% CAGR.
- Mérieux NutriSciences’ 2025 acquisition of Bureau Veritas food-testing activities expanded laboratory footprint in the Americas, Africa, and Asia Pacific, including Ecuador and Peru.
- Middle East & Africa is the smallest regional market at 6.0%, or USD 55.8 million, in 2025, and grows at 5.1% CAGR to USD 91.5 million by 2035, with Gulf import requirements favoring mobile sampling and referral networks over stand-alone high-capital installations.
Competitive Landscape
Structure and recent moves
- The market is moderately concentrated: Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Mérieux NutriSciences Corporation, and QIAGEN N.V. collectively account for approximately 47.7% of 2025 revenue, with Eurofins at approximately 14%.
- Competition separates into laboratory-service networks, instrument and reagent providers, and specialists in molecular or rapid diagnostics.
- Eurofins completed 11 acquisitions in the first quarter of 2025, representing more than EUR 160 million in combined FY2024 pro-forma revenue, and reported 6.9% revenue growth in Q1 2025 with 24% earnings-per-share growth.
- Mérieux NutriSciences completed its acquisition of Bureau Veritas food-testing activities on September 3, 2025, adding 34 laboratories in 15 countries and approximately 1,900 technical staff for an enterprise value of EUR 360 million.
- SGS SA acquired Murray-Brown Laboratories in February 2026, adding a Colorado ISO 17025-accredited food-testing laboratory with PCR pathogen detection and pesticide and mycotoxin capabilities.
- Neogen Corporation sold its cleaners and disinfectants business to Kersia in July 2025 for USD 130 million, sharpening its focus on food-safety diagnostics relevant to allergen and toxin testing in spice ingredients and blends.
- Thermo Fisher Scientific Inc. supplies chromatography, mass-spectrometry, PCR, and sequencing workflows, including an NGS food-authenticity workflow validated for species identification in herbs and spices.
- Agilent Technologies Inc. is positioned in LC and ICP-MS platforms used for residue panels and elemental analysis, lowering validation burdens for testing laboratories.
- QIAGEN N.V. provides nucleic-acid extraction, qPCR, digital-PCR, and sequencing-enabling products, while Bio-Rad Laboratories Inc. offers qPCR and digital-PCR workflows for pathogen and species work.
- Intertek Group plc and TÜV Rheinland Group link accredited testing to audits and supplier compliance programs; GEN-IAL GmbH specializes in food-fraud PCR assays and LeafWorks, Inc. focuses on genomic profiling for botanical verification.
- Network operators must add fast, validated screening without compromising confirmation quality; platform suppliers must show that systems fit accredited workflows and shorten release cycles.
- Acquisitions strengthen geographic coverage, but durable differentiation depends on converting disparate results into a credible, lot-specific evidence trail.
Laboratory-service networks
- Eurofins Scientific SE
- Mérieux NutriSciences Corporation
- Bureau Veritas SA
- SGS SA
- Intertek Group plc
- TÜV Rheinland Group
Instrument and diagnostic suppliers
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- QIAGEN N.V.
- Bio-Rad Laboratories Inc.
- Neogen Corporation
- GEN-IAL GmbH
- LeafWorks, Inc.